News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma

News

February 7, 2024
PRESS RELEASE: On February 5, 2024, a new research perspective was published in Oncotarget, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.” continue reading »

Epigenetic Drift Underlies Epigenetic Clock Signals, but…

Aging

February 6, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 2, entitled, “Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation.” continue reading »

Drug Discovery in Academia; Dumping in the Publication Landfill?

News

February 5, 2024
PRESS RELEASE: On January 24, 2024, a new editorial was published in Oncotarget, entitled, “The fate of drug discovery in academia; dumping in the publication landfill?” continue reading »

Prognostic Significance of Senescence-related TME Genes in Head and Neck Squamous Cell Carcinoma

Aging

January 31, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 2, entitled, “Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma.” continue reading »

BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients

News

January 31, 2024
PRESS RELEASE: On January 24, 2024, a new research paper was published in Oncotarget, entitled, “BCAS1 defines a heterogeneous cell population in diffuse gliomas.” continue reading »